MedPath

Assmenat addition of autologous platelet-rich plasma in premature ovarian failur effect rejuvenalizatio

Phase 2
Recruiting
Conditions
premature ovarian failur.
Primary ovarian failure
E28.3
Registration Number
IRCT20151123025202N2
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Women with amenorrhea before the age of 40

Exclusion Criteria

Amenorrhea due to a specific illness

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Treatment of infertility. Timepoint: At intervention time(Base), 2, 6 and 12 months after intervention. Method of measurement: Hormonal testing and ultrasound.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath